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In recent years, research has delved into
the ways the body’s immune system some-
times promotes disease rather than stifling it.
Take inflammation. When you cut yourself,
the red puffiness that ensues, called acute
inflammation, is the body’s way of signaling
that something’s gone wrong and help is
needed. If allgoes well,various immune cells
move in, destroying any pathogens that
might enter the wound and helping to repair
the damaged tissue. As you heal, the
inflammation subsides. However, much like
stress—a natural response to crisis that is
unhealthy as a steady state—inflammation
appears to be useful in the short-term but
bad over the long haul. Chronic low-level
inflammation has been fingered as a root
cause of many diseases, contributing to
conditions from diabetes to cancer.
Research in mice has demonstrated that
immune cells interact extensively with tu-
mors, and not just to fight them off. Rather,
cancers sometimes co-opt the immune
system. For example, macrophages help
guide metastasis, the spread of cancer cells
from advanced tumors to other sites in the
body. However, in mice it’s been difficult to
assess how the immune system interacts with
the earliest stages of tumor development.
When an oncogene (a cancer-promoting
gene) is activated or a tumor suppressor
function lost, a cell can start to grow and
divide faster than its neighbors. Eventually,
transformed cells overtake the surrounding
tissue and form tumors. A new animal
study by Yi Feng and colleagues in the UK
and Italy illuminates how single, newly-
transformed cancer cells engage the body’s
immune response. Rather than mice, the
team used zebrafish, which conserve many
of the molecular and cellular components
of tumor formation seen in mammals.
Moreover, zebrafish larvae offer the ad-
vantage of being translucent, allowing
investigators to live-image the very begin-
nings of tumors, when only one or two cells
have been transformed.
Using zebrafish that had fluorescently
labeled leukocytes, the team used several
different tricks to express the human
oncogene HRAS in early stage embryos.
The oncogene was labeled with a different
colored fluorescent tag and engineered to be
switched on in melanocytes, specific skin
pigment cells, only. The researchers then
monitored the first hours and days of
development. As the embryo grew, some
of the cells were transformed by HRAS, and
those transformed cells actively attracted the
innateimmunecells.Theresearchersgotthe
same results when using a different onco-
g e n e ,S R C ,f o rt h e i re x p e r i m e n t sa n da f t e r
inserting HRAS into a different cell popu-
lation, mucus-secreting cells, and continued
to see the same immune response.
To investigate the analogy that a tumor
resembles a wound, the researchers made a
laser cut in the same region of the zebrafish
larvae where tumors had been observed
and imaged the immune response. Early
immune cells responded to the cut in a very
similar manner. Both wounds and tumor
cells produced H2O2, and the researchers
found that immune cells traveled up the
H2O2 gradient towards the cut or cancer.
However, in the case of the tumor, the
inflammatory response never resolved,
and researchers were able to visualize
competing immune responses. Neutrophils
and macrophages appeared to engulf
cancerous cells, in line with the traditional
‘‘search and destroy’’ conception of im-
mune response. However, other cells
formed cytoplasmic tethers linking them
to cancerous cells, and in some cases the
cancerous cells appeared to drag leuko-
cytes back when they started to leave the
region. The tumors resembled chronic
skin lesions more than acute cuts, support-
ing the common analogy that ‘‘a tumor is
a wound that doesn’t heal.’’
Still, the researchers wanted to know
whether the tumor was avoiding destruc-
tion or actually co-opting the immune cells
in these earliest stages of development. To
test this, they blocked the immune response
in three different ways: they prevented the
development of immune cells for the first
three days after fertilization, and, separate-
ly, they used two different strategies to limit
H2O2 production. In each case, immune
cells failed to migrate to the cancer site.
And each time, when the immune response
was blocked, fewer cancer cells formed.
By visualizing the earliest interactions
between cancer cells and their host environ-
ment, the researchers have shown that even
from their earliest stages tumors don’t just
avoid being destroyed by the immune system.
Rather, they appear to court an immune
response, co-opting the body’s innate im-
mune system to aid and abet their growth.
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Destroyer or facilitator? An immune cell
(red) glides over a doublet of V12Ras-
transformed mucus-secreting cells, pos-
sible precursors of tumors, in a translu-
cent, 3-day-old zebrafish larva.
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